Position Statement: Medical Toxicologist Participation in Medication Management and Safety Systems

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Medical Toxicology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s13181-013-0361-4PMID 25701218PMCID PMC4371022
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• ASHP Guidelines on the Pharmacy and Therapeutics Committee and the Formulary System.

  2019cited by this paper
• The costs of adverse drug events in community hospitals.

  2012cited by this paper
• Improvement in the detection of adverse drug events by the use of electronic health and prescription records: An evaluation of two trigger tools

  2012cited by this paper
• Impact of computerized physician order entry on medication errors.

  2012cited by this paper
• Monitoring adverse drug reactions across a nationwide health care system using information technology.

  2012cited by this paper
• An agenda for UK clinical pharmacology: Medication errors

  2012cited by this paper
• Factors Associated with Reported Preventable Adverse Drug Events: A Retrospective, Case-Control Study

  2012cited by this paper
• Pharmacy and Therapeutics Committees: Leadership Opportunities in Medication Safety for Medical Toxicologists

  2011cited by this paper
• Emergency hospitalizations for adverse drug events in older Americans.

  2011cited by this paper
• Errors in medicine.

  2009cited by this paper
• ASHP guidelines on the pharmacy and therapeutics committee and the formulary system.

  2008cited by this paper
• MedWatch–The FDA Safety Information and Adverse Event-Reporting Program

  2007cited by this paper
• Incidence of adverse events and negligence in hospitalized patients: results of the Harvard Medical Practice Study I*

  2004cited by this paper
• Incidence and types of adverse events and negligent care in Utah and Colorado.

  2000cited by this paper
• American College of Clinical Pharmacology Response to the Institute of Medicine Report “To Err Is Human: Building a Safer Health System”

  2000cited by this paper
• Incidence and Costs of Adverse Drug Reactions During Hospitalisation

  2000cited by this paper
• Frequency, consequences and prevention of adverse drug events.

  1999cited by this paper
• Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group.

  1995cited by this paper
• Incidence of Adverse Drug Events and Potential Adverse Drug Events: Implications for Prevention

  1995cited by this paper
• The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II.

  1991cited by this paper
• The errors of medicine.

  1970cited by this paper

• The Value of Medical Toxicologists

  2025cites this paper
• Human Errors and Adverse Hemodynamic Events Related to “Push Dose Pressors” in the Emergency Department

  2019cites this paper
• Toxicology in the Service of Patient and Medication Safety: a Selected Glance at Past and Present Innovations

  2015cites this paper
• Introduction to Special Issue: At the Precipice of Quality Health Care: The Role of the Toxicologist in Enhancing Patient and Medication Safety

  2015cites this paper